No Matches Found
No Matches Found
No Matches Found
Star Health & Allied Insurance Company Ltd
Star Health & Allied Insurance Sees Technical Momentum Shift Amid Mixed Indicator Signals
Star Health & Allied Insurance Company Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on the daily charts. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent price action and relative strength against the Sensex suggest cautious optimism among investors.
Star Health & Allied Insurance Company Ltd is Rated Hold
Star Health & Allied Insurance Company Ltd is rated 'Hold' by MarketsMOJO. This rating was last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 31 January 2026, providing investors with the most up-to-date analysis.
Are Star Health & Allied Insurance Company Ltd latest results good or bad?
Star Health & Allied Insurance Company Ltd's latest results show a net profit of ₹128.22 crores, a 133.55% increase sequentially but a 40.40% decline year-on-year, with premium growth not translating into improved profitability due to declining margins and rising claims ratios. Overall, the company faces challenges in maintaining its competitive position in the market.
Star Health Q3 FY26: Profit Surge Masks Margin Pressures in Competitive Health Insurance Market
Star Health and Allied Insurance Company Ltd. reported a net profit of ₹128.22 crores for Q3 FY26, marking a robust sequential improvement of 133.55% from Q2 FY26's ₹54.90 crores. However, the year-on-year comparison reveals a more sobering reality, with profits declining 40.40% from ₹215.14 crores in Q3 FY25. The ₹25,442 crore market capitalisation health insurer continues to navigate a challenging landscape where premium growth comes at the cost of profitability margins, raising concerns about sustainable earnings quality in India's fiercely competitive standalone health insurance segment.
Star Health & Allied Insurance Falls 3.47%: Key Technical and Fundamental Drivers This Week
Star Health & Allied Insurance Company Ltd experienced a challenging week ending 23 January 2026, with its stock price declining 3.47% from Rs.440.75 to Rs.425.45. This underperformance slightly exceeded the Sensex’s 3.31% fall over the same period, reflecting a combination of deteriorating financial results, bearish technical signals, and a downgrade to a 'Strong Sell' rating by MarketsMOJO. The week was marked by a steady erosion of investor confidence amid weak quarterly profitability and negative momentum across key technical indicators.
Star Health & Allied Insurance Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
Star Health & Allied Insurance Company Ltd has been downgraded from a Sell to a Strong Sell rating as of 19 Jan 2026, reflecting deteriorating technical indicators and disappointing financial performance. The company’s Mojo Score has declined to 27.0, signalling heightened caution for investors amid a challenging market environment and weakening fundamentals.
Star Health & Allied Insurance Ltd Faces Mildly Bearish Momentum Amid Technical Shifts
Star Health & Allied Insurance Company Ltd has experienced a subtle shift in price momentum, with technical indicators signalling a transition from sideways to mildly bearish trends. Despite some bullish cues on shorter timeframes, the overall technical landscape suggests caution for investors amid recent market volatility.
Star Health Gains 3.88%: 2 Key Factors Driving the Week’s Momentum
Star Health & Allied Insurance Company Ltd recorded a weekly gain of 3.88%, closing at Rs.460.35 on 2 January 2026, outperforming the Sensex which rose 1.35% over the same period. The week was marked by a notable technical momentum shift amid mixed market signals and a significant downgrade to a Strong Sell rating by MarketsMOJO, reflecting deteriorating financials and bearish technical indicators.
Star Health & Allied Insurance Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
Star Health & Allied Insurance Company Ltd has been downgraded from a Sell to a Strong Sell rating as of 1 January 2026, reflecting deteriorating technical indicators and disappointing financial results. Despite some positive long-term fundamentals, the company faces valuation concerns and a weakening technical trend, prompting a cautious stance from analysts.
Star Health & Allied Insurance Sees Technical Momentum Shift Amid Mixed Market Signals
Star Health & Allied Insurance Company Ltd has experienced a subtle shift in price momentum, with technical indicators signalling a transition from a sideways trend to a mildly bearish stance. Despite a modest daily gain of 1.71%, the broader technical landscape suggests caution for investors as several key metrics point towards weakening momentum in the medium term.
Why is Star Health & Allied Insurance Company Ltd falling/rising?
As of 26-Dec, Star Health & Allied Insurance Company Ltd’s stock price has fallen sharply, reflecting mounting concerns over its deteriorating sales performance and profitability, despite some long-term operational strengths.
Star Health Insu Sees Revision in Market Assessment Amidst Challenging Financial Trends
Star Health Insu has experienced a revision in its market evaluation, reflecting recent developments across key financial and technical parameters. This shift highlights the evolving challenges faced by the company within the insurance sector, particularly in light of its valuation and financial performance.
Star Health & Allied Insurance Company Faces Mixed Technical Signals Amid Sideways Momentum
Star Health & Allied Insurance Company is currently navigating a phase of sideways price momentum, with technical indicators presenting a complex picture. Recent assessment changes reveal a shift from mildly bullish trends to a more neutral stance, reflecting a period of consolidation in the insurance sector stock.
Star Health & Allied Insurance Company: Technical Momentum Shifts Signal Mixed Market Sentiment
Star Health & Allied Insurance Company has experienced a notable shift in its technical momentum, reflecting a nuanced market assessment amid evolving evaluation parameters. While some indicators suggest emerging bullish tendencies, others continue to signal caution, painting a complex picture for investors in the insurance sector.
Star Health & Allied Insurance Company Faces Mixed Technical Signals Amid Price Momentum Shift
Star Health & Allied Insurance Company has experienced a notable shift in its price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bullish trend to a sideways movement. This development comes amid a broader market context where the stock's recent performance contrasts with benchmark indices, prompting a closer examination of its technical landscape.
Is Star Health Insu technically bullish or bearish?
As of December 1, 2025, the trend is mildly bullish due to positive short-term signals, but mixed longer-term indicators suggest caution.
Star Health & Allied Insurance Company: Analytical Review Highlights Key Evaluation Shifts
Star Health & Allied Insurance Company has undergone a revision in its market assessment, reflecting nuanced changes across quality, valuation, financial trends, and technical indicators. This article explores the underlying factors influencing the recent analytical perspective adjustments, providing investors with a comprehensive understanding of the company’s current standing within the insurance sector.
Star Health & Allied Insurance Company: Technical Momentum and Market Assessment Update
Star Health & Allied Insurance Company has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a mild adjustment in the company’s evaluation metrics, with price movements and technical indicators suggesting a cautious outlook amid broader sector dynamics.
How has been the historical performance of Star Health Insu?
Star Health Insu has shown significant growth, with net sales increasing from 4,626.63 Cr in Mar'21 to 14,822.20 Cr in Mar'25, and profit after tax improving from a loss of 1,085.71 Cr to a profit of 645.86 Cr in the same period. Despite fluctuations in operating profit, total assets rose to 20,433.42 Cr in Mar'25, and cash flow from operations turned positive with a net inflow of 223.00 Cr.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
